MedPath

TREATMENT OF HYPOTENSION IN EXTREMELY PRETERM INFANTS: A MULTICENTER RANDOMIZED CONTROLLED TRIAL - ND

Conditions
HYPOTENSION IN EXTREMELY PRETERM INFANTS
MedDRA version: 9.1Level: LLTClassification code 10049223
Registration Number
EUCTR2009-016653-17-IT
Lead Sponsor
AZIENDA UNITA` SANITARIA LOCALE N 12 DI VIAREGGIO
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

premature neonates 23-30 weeks gestation that present hypotension (BP < threshold for at least 10 minutes), and whose parents have given an informed consent to the study. The BP threshold for inclusion is based on GA (Attachment 1).
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) no
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Congenital heart diseases (except patent ductus arteriosus) identified by echocardiography; Severe /lethal congenital anomalies; Massive hemorrhage; neonates only offered supportive/palliative care; hypotension occurring > 3 days of life

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath